Chinese english Germany Japanese Korea

(R)-2-((R)-6,7-dimethoxy-1-(4-(trifluoromethyl)phenethyl)-3,4-dihydroisoquinolin-2(1H)-yl)-N-methyl-2-phenylacetamide

(R)-2-((R)-6,7-dimethoxy-1-(4-(trifluoromethyl)phenethyl)-3,4-dihydroisoquinolin-2(1H)-yl)-N-methyl-2-phenylacetamide Struktur
871224-64-5
CAS-Nr.
871224-64-5
Englisch Name:
(R)-2-((R)-6,7-dimethoxy-1-(4-(trifluoromethyl)phenethyl)-3,4-dihydroisoquinolin-2(1H)-yl)-N-methyl-2-phenylacetamide
Synonyma:
CS-1665;Almorexant;Act-078573;AlMorexant HCl;Almorexant [inn];almorexant (ACT-078573);ACT-078573;ACT 078573;ACT078573;almorexant (ACT-078573), CID 23727689;2-(6,7-dimethoxy-1-(4-(trifluoromethyl)phenethyl)-3,4-dihydroisoquinolin-2(1H)-yl)-N-methyl-2-phenylacetamide;3,4-Dihydro-6,7-dimethoxy-N-methyl-alpha-phenyl-1-[2-[4-(trifluoromethyl)phenyl]ethyl]-2(1H)-isoquinolineacetamide
CBNumber:
CB61512403
Summenformel:
C29H31F3N2O3
Molgewicht:
512.56
MOL-Datei:
871224-64-5.mol
Request For Quotation

(R)-2-((R)-6,7-dimethoxy-1-(4-(trifluoromethyl)phenethyl)-3,4-dihydroisoquinolin-2(1H)-yl)-N-methyl-2-phenylacetamide Eigenschaften

Siedepunkt:
620.4±55.0 °C(Predicted)
Dichte
1.205
storage temp. 
Desiccate at -20°C
Löslichkeit
Soluble in DMSO
Aggregatzustand
Powder
pka
15.04±0.46(Predicted)

Sicherheit

(R)-2-((R)-6,7-dimethoxy-1-(4-(trifluoromethyl)phenethyl)-3,4-dihydroisoquinolin-2(1H)-yl)-N-methyl-2-phenylacetamide Chemische Eigenschaften,Einsatz,Produktion Methoden

(R)-2-((R)-6,7-dimethoxy-1-(4-(trifluoromethyl)phenethyl)-3,4-dihydroisoquinolin-2(1H)-yl)-N-methyl-2-phenylacetamide Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

(R)-2-((R)-6,7-dimethoxy-1-(4-(trifluoromethyl)phenethyl)-3,4-dihydroisoquinolin-2(1H)-yl)-N-methyl-2-phenylacetamide Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 72)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Hubei Jusheng Technology Co.,Ltd. 		18871490254
linda@hubeijusheng.com CHINA 28180 58
BOC Sciences 		+1-631-485-4226
inquiry@bocsci.com United States 19553 58
CONIER CHEM AND PHARMA LIMITED 		+8618523575427
 sales@conier.com China 47465 58
TargetMol Chemicals Inc. 		+1-781-999-5354 +1-00000000000
 marketing@targetmol.com United States 19892 58
Finetech Industry Limited 		+86-27-87465837 +8618971612321
 info@finetechnology-ind.com China 9702 58
Baoji Guokang Bio-Technology Co., Ltd. 		0917-3909592 13892490616
 gksales1@gk-bio.com China 9339 58
Guangzhou TongYi biochemistry technology Co.,LTD 		+8613073028829
 mack@tongyon.com China 2996 58
Alfa Chemistry 		+1-5166625404
Info@alfa-chemistry.com United States 21317 58
InvivoChem 		+1-708-310-1919 +1-13798911105
 sales@invivochem.cn United States 6393 58
LEAPCHEM CO., LTD. 		+86-852-30606658
market18@leapchem.com China 43348 58
  • (R)-2-((R)-6,7-dimethoxy-1-(4-(trifluoromethyl)phenethyl)-3,4-dihydroisoquinolin-2(1H)-yl)-N-methyl-2-phenylacetamide
  • Almorexant
  • 2-(6,7-dimethoxy-1-(4-(trifluoromethyl)phenethyl)-3,4-dihydroisoquinolin-2(1H)-yl)-N-methyl-2-phenylacetamide
  • 3,4-Dihydro-6,7-dimethoxy-N-methyl-alpha-phenyl-1-[2-[4-(trifluoromethyl)phenyl]ethyl]-2(1H)-isoquinolineacetamide
  • (2R)-2-((1S)-6,7-Dimethoxy-1-{2-(4-(trifluoromethyl)phenyl)ethyl}-3,4-dihydroisoquinolin-2(1H)-yl)-N-methyl-2-phenylacetamide
  • Act-078573
  • Almorexant [inn]
  • AlMorexant HCl
  • 2(1H)-IsoquinolineacetaMide,3,4-dihydro-6,7-diMethoxy-N-Methyl-a-phenyl-1-[2-[4-(trifluoroMethyl)phenyl]ethyl]-, (aR,1S)-
  • Act-078573 (R)-2-((R)-6,7-dimethoxy-1-(4-(trifluoromethyl)phenethyl)-3,4-dihydroisoquinolin-2(1H)-yl)-N-methyl-2-phenylacetamide
  • 2(1H)-Isoquinolineacetamide, 3,4-dihydro-6,7-dimethoxy-N-methyl-α-phenyl-1-[2-[4-(trifluoromethyl)phenyl]ethyl]-, (αR,1S)-
  • CS-1665
  • ACT-078573;ACT 078573;ACT078573
  • almorexant (ACT-078573), CID 23727689
  • almorexant (ACT-078573)
  • (2R)-2-[(1S)-6,7-DIMETHOXY-1-[2-[4-(TRIFLUOROMETHYL)PHENYL]ETHYL]-3,4-DIHYDRO-1H-ISOQUINOLIN-2-YL]-N-METHYL-2-PHENYLACETAMIDE
  • pancreatic cancer,Orexin Receptor (OX Receptor),Pancreatic ductal adenocarcinoma,Cataplexy,ACT078573,Almorexant,HCRT Receptor,Inhibitor,Apoptosis,GPCR,orexin,Hypocretin Receptor,Ca2+ channels,narcolepsy,Caspase,HPAF-II cells,AsPC-1 cells,Calcium Channel,Ca channels,hypocretin,ACT-078573,inhibit,PDAC
  • 871224-64-5
  • C29H31F3N2O3
  • Inhibitors
  • API intermediates
Copyright 2019 © ChemicalBook. All rights reserved